What is CVE-2023-38954?

CVE-2023-38954 is a critical-severity vulnerability in Zkteco Bioaccess Ivs, classified under SQL Injection. CVSS score: 9.8/10. Published 2023-08-03.

How severe is CVE-2023-38954?

Critical severity. CVSS v3 base score is 9.8 out of 10.

SQL Injection in Zkteco Bioaccess Ivs

CVE-2023-38954

ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.

Vulnerability class: SQL Injection

EPSS: 0.005 (40.2th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

Affected products

Zkteco Bioaccess_ivs — versions 3.3.1
N/a — versions n/a

Weakness classification (CWE)

CWE-89 — SQL Injection

References

af854a3a-2127-422b-91ae-364da2661108 (Not Applicable)
cve@mitre.org (Third Party Advisory)

Frequently asked questions

What is CVE-2023-38954?: CVE-2023-38954 is a critical-severity vulnerability in Zkteco Bioaccess Ivs, classified under SQL Injection. CVSS score: 9.8/10. Published 2023-08-03.
How severe is CVE-2023-38954?: Critical severity. CVSS v3 base score is 9.8 out of 10.